Insilico Medicine’s Generative AI-designed Drug ISM001-055 Shows Promising Results in Phase IIa Clinical Trials In a breakthrough for AI-powered...
Vous n'êtes pas connecté
Injectable HIV Prevention Drug Shows Promising Results By Thuku Kariuki and Daniel Furnad An injectable medication to prevent the transmission of HIV, taken twice a year, has successfully passed the first clinical trial in South Africa and Uganda. Lenacapavir, developed by Gilead Sciences, a research-based biopharmaceutical company in the US, will mark a significant advancement […]
Insilico Medicine’s Generative AI-designed Drug ISM001-055 Shows Promising Results in Phase IIa Clinical Trials In a breakthrough for AI-powered...
Diary highlights this week include a webinar on the twice-yearly Lenacapavir injection for HIV prevention, green hydrogen’s role in South Africa’s...
Results from a late-stage study on RHHBY's Xofluza show that the drug reduces the transmission of influenza from an infected person to household...
The latest trading day saw Gilead Sciences (GILD) settling at $83.08, representing a -0.1% change from its previous close.
THURSDAY, Sept. 26, 2024 -- The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and...
A new study by scientists in Japan has discovered that proteins found in foods like meat and milk may help prevent the growth of tumors in the small...
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the...
In her final hours, Amber Nicole Thurman suffered from a grave infection that her suburban Atlanta hospital was well-equipped to treat. She’d taken...
by Kavitha SuranaProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one...
Utility companies in the United States could double electric transmission capacity by 2035 by replacing existing transmission lines with those made...